液化空气集团通过对德国和比荷卢糖尿病患者的支持，加强了其家庭医疗服务

液化空气集团正致力于在欧洲家庭医疗保健领域的发展，为德国、比利时、荷兰和卢森堡的糖尿病患者提供更广泛的服务。该组织已经为全世界160万慢性病患者提供家庭护理。液化空气公司利用其在支持呼吸系统疾病患者方面的经验，将医疗设备、个性化患者随访和相关数字服务的开发结合起来。

在德国和比荷卢，液化空气公司正利用其在复杂慢性病家庭护理领域的历史地位，为糖尿病患者提供这一新服务。从现在起，液化空气公司将在欧洲10个国家为糖尿病患者提供支持，其中包括法国，该集团在法国开展这项活动已有近20年。

Air Liquide has chosen the technology of Tandem Diabetes Care, a manufacturer of medical devices for diabetic patients, to provide its patients in Germany and Benelux with state-of-the-art insulin pumps as part of its services offer. The insulin pump, combined with a continuous glucose monitoring system, makes it possible to anticipate the risks of hypoglycemia and automatically suspend the delivery of insulin, facilitating the use of the pump on a daily basis. Air Liquide is already a partner of Tandem Diabetes Care in other European countries.

The number of patients with diabetes is growing: an estimated 60 million people in Europe suffer from this disease. Type 1 diabetes, i.e. insulin-dependent diabetes, is a chronic illness that requires personalized support over the long term to enable patients to live as well as possible with the disease. A leader in home healthcare in Europe, Air Liquide seeks to increase the autonomy and quality of life of patients, improve their adherence to treatment and prevent the risk of complications or re-hospitalization.

弗朗索瓦·杰科，Executive Vice President and member of the Air Liquide Executive Committee supervising in particular the Healthcare world business line:

液化空气公司继续在欧洲开发其家庭医疗服务，以满足复杂慢性病患者日益增长的需求。凭借30多年的经验，该集团将最新的技术和数字创新与个性化的患者支持相结合，为患者提供服务。因此，液化空气公司将继续致力于改善全球160多万患者的生活质量。